Evidence map›Paper›PMID 20925932›Full record

ArticleBMC systems biology2010

Edelfosine-induced metabolic changes in cancer cells that precede the overproduction of reactive oxygen species and apoptosis.

Vitaly A Selivanov, Pedro Vizán, Faustino Mollinedo, Teresa W M Fan, Paul W N Lee, Marta Cascante

Open access · diamondAbstract read
In one paragraph

Article in BMC systems biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Applications of NMR spectroscopy to systems biochemistry.Progress in nuclear magnetic resonance spectroscopy · 2016
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Vitaly A SelivanovDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Institute of Biomedicine of University of Barcelona (IBUB) and IDIBAPS, Unit Associated with CSIC, Barcelona, Spain.
Pedro Vizán
Faustino Mollinedo
Teresa W M Fan
Paul W N Lee
Marta Cascante
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESConsejo Superior de Investigaciones Científicas · ESUCLA Medical Center · USUniversity of Louisville · US

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ANDERSON, GAIL V · 1985 to 2011
$74.2M
UCLA Center for Excellence in Pancreatic DiseasesP01AT003960 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HINES, OSCAR JOE · 2007 to 2011
$5.6M
Biochemical Mechanisms of Se Anticancer Activity in LungR01CA118434 · NCI · UNIVERSITY OF LOUISVILLE · PI FAN, TERESA WHEI-MEI · 2008 to 2011
$1.4M
Selenium Prevention of Tobacco Smoke-Induced Lung CancerR01CA101199 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FAN, TERESA W-M · 2003 to 2005
$704k
NCCIH NIH HHS P01 AT003960-01NCI NIH HHS 1R01CA101199-01NCI NIH HHS 1R01CA118434-01A2NCRR NIH HHS M01 RR00425-33
6 · The paper itself

Abstract

backgroundMetabolic flux profiling based on the analysis of distribution of stable isotope tracer in metabolites is an important method widely used in cancer research to understand the regulation of cell metabolism and elaborate new therapeutic strategies. Recently, we developed software Isodyn, which extends the methodology of kinetic modeling to the analysis of isotopic isomer distribution for the evaluation of cellular metabolic flux profile under relevant conditions. This tool can be applied to reveal the metabolic effect of proapoptotic drug edelfosine in leukemia Jurkat cell line, uncovering the mechanisms of induction of apoptosis in cancer cells.

resultsThe study of 13C distribution of Jukat cells exposed to low edelfosine concentration, which induces apoptosis in ≤5% of cells, revealed metabolic changes previous to the development of apoptotic program. Specifically, it was found that low dose of edelfosine stimulates the TCA cycle. These metabolic perturbations were coupled with an increase of nucleic acid synthesis de novo, which indicates acceleration of biosynthetic and reparative processes. The further increase of the TCA cycle fluxes, when higher doses of drug applied, eventually enhance reactive oxygen species (ROS) production and trigger apoptotic program.

conclusionThe application of Isodyn to the analysis of mechanism of edelfosine-induced apoptosis revealed primary drug-induced metabolic changes, which are important for the subsequent initiation of apoptotic program. Initiation of such metabolic changes could be exploited in anticancer therapy.

Indexed as

Antineoplastic AgentsApoptosisGlucoseHumansIsotopesJurkat CellsLactic AcidPhospholipid EthersPrecursor T-Cell Lymphoblastic Leukemia-LymphomaReactive Oxygen SpeciesAntineoplastic AgentsedelfosineGlucoseIsotopesLactic AcidPhospholipid EthersReactive Oxygen Species

Identifiers

PMID20925932
PMCPMC2984393
OpenAlexW2153892445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.